Literature DB >> 12667823

Suppression of an intrinsic strand transfer activity of HIV-1 Tat protein by its second-exon sequences.

Xiaofeng Guo1, Masanori Kameoka, Xin Wei, Bernard Roques, Matthias Gotte, Chen Liang, Mark A Wainberg.   

Abstract

The Tat protein of human immunodeficiency virus type 1 (HIV-1) has been shown to restrict premature reverse transcription at late stages of virus infection and to thus ensure the integrity of the viral RNA genome for packaging. To gain further insights into the roles of Tat in HIV-1 reverse transcription, we have assessed its effects on the first-strand transfer during the synthesis of minus-strand DNA through use of a reconstituted cell-free system. The results demonstrated that a form of Tat, containing only the first exon (Tat72), was able to enhance the first-strand transfer as efficiently as did the viral nucleocapsid protein. Coincidentally, this form of Tat was unable to inhibit the production of minus-strand strong-stop DNA. Further studies with various mutated forms of Tat showed that its Cys-rich region, rather than the core and Arg-rich domains, was essential for this strand transfer activity. Moreover, this activity of Tat is largely independent of the TAR RNA structure. Although full-length Tat protein (Tat86) was also able to promote strand transfer, this activity was limited by a strong overall inhibition of reverse transcription because of the presence of the second Tat exon. Other nucleic-acid-binding proteins (e.g., single-strand DNA-binding protein) were employed as negative controls and were unable to promote strand transfer in these assays. We propose that Tat possesses nucleic acid chaperone activity and can promote the first-strand transfer during HIV-1 reverse transcription; however, these activities are restricted by the second Tat exon, and the roles of these Tat activities in viral replication remain to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12667823     DOI: 10.1016/s0042-6822(02)00068-5

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  10 in total

Review 1.  Nucleocapsid protein function in early infection processes.

Authors:  James A Thomas; Robert J Gorelick
Journal:  Virus Res       Date:  2008-02-14       Impact factor: 3.303

2.  A mutant tat protein inhibits HIV-1 reverse transcription by targeting the reverse transcription complex.

Authors:  Min-Hsuan Lin; Ann Apolloni; Vincent Cutillas; Haran Sivakumaran; Sally Martin; Dongsheng Li; Ting Wei; Rui Wang; Hongping Jin; Kirsten Spann; David Harrich
Journal:  J Virol       Date:  2015-02-11       Impact factor: 5.103

Review 3.  Protein intrinsic disorder as a flexible armor and a weapon of HIV-1.

Authors:  Bin Xue; Marcin J Mizianty; Lukasz Kurgan; Vladimir N Uversky
Journal:  Cell Mol Life Sci       Date:  2011-10-28       Impact factor: 9.261

4.  Modifications in host cell cytoskeleton structure and function mediated by intracellular HIV-1 Tat protein are greatly dependent on the second coding exon.

Authors:  M R López-Huertas; S Callejas; D Abia; E Mateos; A Dopazo; J Alcamí; M Coiras
Journal:  Nucleic Acids Res       Date:  2010-02-05       Impact factor: 16.971

Review 5.  HIV and Alzheimer's disease: complex interactions of HIV-Tat with amyloid β peptide and Tau protein.

Authors:  Alina Hategan; Eliezer Masliah; Avindra Nath
Journal:  J Neurovirol       Date:  2019-04-23       Impact factor: 2.643

6.  The HIV-1 transcriptional activator Tat has potent nucleic acid chaperoning activities in vitro.

Authors:  Monika Kuciak; Caroline Gabus; Roland Ivanyi-Nagy; Katharina Semrad; Roman Storchak; Olivier Chaloin; Sylviane Muller; Yves Mély; Jean-Luc Darlix
Journal:  Nucleic Acids Res       Date:  2008-04-28       Impact factor: 16.971

7.  HIV Tat protein and amyloid-β peptide form multifibrillar structures that cause neurotoxicity.

Authors:  Alina Hategan; Mario A Bianchet; Joseph Steiner; Elena Karnaukhova; Eliezer Masliah; Adam Fields; Myoung-Hwa Lee; Alex M Dickens; Norman Haughey; Emilios K Dimitriadis; Avindra Nath
Journal:  Nat Struct Mol Biol       Date:  2017-02-20       Impact factor: 15.369

8.  Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones.

Authors:  Joshua Baalwa; Shuyi Wang; Nicholas F Parrish; Julie M Decker; Brandon F Keele; Gerald H Learn; Ling Yue; Eugene Ruzagira; Deogratius Ssemwanga; Anatoli Kamali; Pauli N Amornkul; Matt A Price; John C Kappes; Etienne Karita; Pontiano Kaleebu; Eduard Sanders; Jill Gilmour; Susan Allen; Eric Hunter; David C Montefiori; Barton F Haynes; Emmanuel Cormier; Beatrice H Hahn; George M Shaw
Journal:  Virology       Date:  2012-11-01       Impact factor: 3.616

9.  Study of E. coli Hfq's RNA annealing acceleration and duplex destabilization activities using substrates with different GC-contents.

Authors:  Martina Doetsch; Sabine Stampfl; Boris Fürtig; Mads Beich-Frandsen; Krishna Saxena; Meghan Lybecker; Renée Schroeder
Journal:  Nucleic Acids Res       Date:  2012-10-26       Impact factor: 16.971

10.  Vif is a RNA chaperone that could temporally regulate RNA dimerization and the early steps of HIV-1 reverse transcription.

Authors:  S Henriet; L Sinck; G Bec; R J Gorelick; R Marquet; J-C Paillart
Journal:  Nucleic Acids Res       Date:  2007-07-26       Impact factor: 16.971

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.